Status:
COMPLETED
Stellate Ganglion Block in Patients With Cerebral Small Vessel Disease
Lead Sponsor:
Zeng Changhao
Conditions:
Dysphagia
Cerebral Small Vessel Diseases
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
A prospective study was conducted on 84 CSVD patients with dysphagia and cognitive impairment. They were divided into the comparison group and observation group evenly. All the patients were provided ...
Detailed Description
In order to observe the effect of stellate ganglion block (SGB) on swallowing function, cognitive function and activities of daily living in patients with cerebral small vessel disease (CSVD), A prosp...
Eligibility Criteria
Inclusion
- Age\>18 years.
- Meeting the diagnostic criteria for cerebral small vessel disease Imaging proposed in 2013 by the international cerebral small vessel disease Expert Group, and the "Consensus on Diagnosis and Treatment of Cerebral Small Vessel Disease in China" in 2017.
- Dysphagia confirmed by Videofluoroscopic Swallowing Study
- Mini-Mental State Examination (MMSE)\<27, indicating the existence of cognitive impairment.
- No history of prior stroke.
- Stable vital signs.
Exclusion
- Dysphagia that might be caused by other diseases that might cause dysphagia, such as head and neck tumors, traumatic brain injury, myasthenia gravis, etc.
- Cognitive impairment that might be caused by other diseases, such as Alzheimer's disease, Parkinson's disease, brain injury, etc.
- Neurological blockade contraindications such as bleeding tendency, blocked site infection.
- MMSE\<10, or unable to successfully finish the assessment of this study (Patients with severe mental illness or intellectual disability might have difficulty to cooperate with the assessment).
- Complicated with severe liver and kidney failure, tumors, or hematological disorders.
- Simultaneously in need to undergo other therapy that might affect the outcomes of this study.
- Pregnant or nursing females.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 31 2023
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT06176404
Start Date
February 1 2021
End Date
May 31 2023
Last Update
August 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhen Da No.1 Fushu Hos.
Huabei, China